Recent Updates
Recently added Catalysts
PALI Positive Sentiment Score: 70/100

Palisade Bio to Participate in the Virtual Investor Lunch Break Event

Thursday, April 11, 2024 2 min read
Key Takeaway: Palisade Bio, a biopharmaceutical company, has announced its participation in an upcoming Virtual Investor Lunch Break event scheduled for April 16, 2024. The event will feature presentations from CEO J.D. Finley and CMO Dr. Mitch Jones, who will provide an overview of the company's strategies and opportunities. A live webcast of the presentation will be accessible on the company’s website, and a replay will also be available afterward. This engagement underscores Palisade's commitment to investor relations and communication.

Market Sentiment Analysis

POSITIVE FACTORS

  • Palisade Bio is actively engaging with investors, indicating transparency.
  • The participation highlights the company's dedication to corporate communication.
  • The event will feature insights from key executives, suggesting confidence in their strategy.

Full Press Release Details

– Live webcast with members of Palisade Bio management on Tuesday, April 16th at 12:00 PM ET
Carlsbad, CA, April 11, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that it will present at the Virtual Investor Lunch Break Featuring Palisade Bio event on Tuesday, April 16, 2024 at 12:00 PM ET.
As part of the event, J.D. Finley, Chief Executive Officer and Dr. Mitch Jones, Chief Medical Officer of Palisade Bio, will provide a corporate overview, business outlook, and discuss the Palisade Bio opportunity.
A live video webcast of the presentation will be available on the Events page of the Investors section of the Company’s website (www.palisadebio.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.
Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.
Investor Relations Contact

Tags

biopharmaceutical company
advancing novel therapeutics
Virtual Investor Lunch Break

Frequently Asked Questions

When is the Palisade Bio webcast scheduled?

The live webcast is on April 16, 2024, at 12:00 PM ET.

Who will present during the Palisade Bio event?

J.D. Finley and Dr. Mitch Jones will present at the event.

Where can I watch the Palisade Bio webcast?

The webcast can be viewed on the company's Events page.

How long will the webcast replay be available?

The replay will be accessible for 90 days after the event.

What focus areas does Palisade Bio specialize in?

Palisade Bio focuses on therapeutics for autoimmune, inflammatory, and fibrotic diseases.

Tags: PALI Viatris Investor Conferences Healthcare Palisade Bio virtual event investor relations biopharmaceuticals
Last updated: Apr 11, 2024